Skip Navigation


Rheumatology Advance Access originally published online on August 9, 2006
Rheumatology 2006 45(10):1185-1186; doi:10.1093/rheumatology/kel247
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/10/1185    most recent
kel247v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Carreira, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carreira, P. E.
Related Collections
Right arrow Systemic Sclerosis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

EDITORIALS

‘Quality of pain’ in systemic sclerosis

P. E. Carreira

Rheumatology Department, ‘12 de Octubre’ University Hospital, Madrid, Spain

Correspondence to: Patricia E. Carreira, Servicio de Reumatología, Hospital 12 de Octubre, Avda. de Córdoba s/n, 28041 Madrid, Spain. E-mail: carreira@h12o.es

The first 150 words of the full text of this article appear below.

In the last three decades, measurement of quality of life has become a standard tool to evaluate the impact of disease and therapies in the field of rheumatology. For many years, patient's questionnaires were considered weak ‘subjective’ measures compared with stronger ‘objective’ measures assessed by health professionals. Nevertheless, this point of view changed for many rheumatologists after the demonstration that patient's questionnaire scores are able to predict mortality in patients with rheumatoid arthritis (RA) more effectively than any traditional measure [1]. Patient-reported outcomes give fundamental information about patient's health, functional status, disease symptoms, treatment preferences, satisfaction and quality of life from their own perspective. The two more extended tools to evaluate quality of life in rheumatic patients are the Health Assessment Questionnaire (HAQ) and the Medical Outcome Study (MOS) Short-Form 36 (SF-36). The HAQ was developed for patients with rheumatic diseases, namely RA, in 1980 [2]. . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?